Literature DB >> 11478590

Thiocyanate as a probe of the cystic fibrosis transmembrane conductance regulator chloride channel pore.

P Linsdell1.   

Abstract

Immediately following exposure to thiocyanate (SCN-)-containing solutions, the cystic fibrosis conductance regulator Cl- channel exhibits high unitary SCN conductance and anomalous mole fraction behaviour, suggesting the presence of multiple anion binding sites within the channel pore. However, under steady-state conditions SCN-conductance is very low. Here I show, using patch clamp recording from CFTR-transfected mammalian cell lines, that under steady-state conditions neither SCN- conductance nor SCN- permeability show anomalous mole fraction behaviour. Instead, SCN conductance, permeability, and block of Cl- permeation can all be reproduced by a rate theory model that assumes only a single intrapore anion binding site. These results suggest that under steady-state conditions the interaction between SCN- and the CFTR channel pore can be understood by a simple model whereby SCN- ions enter the pore more easily than Cl-, and bind within the pore more tightly than Cl-. The implications of these findings for investigating and understanding the mechanism of anion permeation are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478590

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  15 in total

1.  Molecular determinants of Au(CN)(2)(-) binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl(-) channel pore.

Authors:  Xiandi Gong; Susan M Burbridge; Elizabeth A Cowley; Paul Linsdell
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

2.  Histologic evaluation of effect of thiocyanate topical application on hamster cheek pouch.

Authors:  Fernanda Gonçalves Salum; Karen Cherubini; Maria Antonia Zancanaro de Figueiredo; Milton de Oliveira Amado; Eloni Terezinha Rodrigues; Liliane Soares Yurgel
Journal:  Clin Oral Investig       Date:  2006-06-07       Impact factor: 3.573

3.  Probing an open CFTR pore with organic anion blockers.

Authors:  Zhen Zhou; Shenghui Hu; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2002-11       Impact factor: 4.086

4.  Coupled movement of permeant and blocking ions in the CFTR chloride channel pore.

Authors:  Xiandi Gong; Paul Linsdell
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

5.  The thiocyanate analog selenocyanate is a more potent antimicrobial pro-drug that also is selectively detoxified by the host.

Authors:  Brian J Day; Preston E Bratcher; Joshua D Chandler; Matthew B Kilgore; Elysia Min; John J LiPuma; Robert J Hondal; David P Nichols
Journal:  Free Radic Biol Med       Date:  2019-11-15       Impact factor: 7.376

6.  On the origin of asymmetric interactions between permeant anions and the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  Mohammad Fatehi; Chantal N St Aubin; Paul Linsdell
Journal:  Biophys J       Date:  2006-12-01       Impact factor: 4.033

7.  Novel residues lining the CFTR chloride channel pore identified by functional modification of introduced cysteines.

Authors:  Mohammad Fatehi; Paul Linsdell
Journal:  J Membr Biol       Date:  2009-04-19       Impact factor: 1.843

8.  Mouse bestrophin-2 is a bona fide Cl(-) channel: identification of a residue important in anion binding and conduction.

Authors:  Zhiqiang Qu; Rodolphe Fischmeister; Criss Hartzell
Journal:  J Gen Physiol       Date:  2004-04       Impact factor: 4.086

9.  Transcellular thiocyanate transport by human airway epithelia.

Authors:  Miryam A Fragoso; Vania Fernandez; Rosanna Forteza; Scott H Randell; Matthias Salathe; Gregory E Conner
Journal:  J Physiol       Date:  2004-09-02       Impact factor: 5.182

10.  Mutations at arginine 352 alter the pore architecture of CFTR.

Authors:  Guiying Cui; Zhi-Ren Zhang; Andrew R W O'Brien; Binlin Song; Nael A McCarty
Journal:  J Membr Biol       Date:  2008-04-18       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.